Showing results (311-320 of 426) with videos related to

Sort By:
Pageof 43
Plos One|September 26, 2015
Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON ConsortiumKatarina Lagergren, Weronica E Ek, David Levine, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST)Fátima Carneiro, Cátia Moutinho, Guillem Pera, et al.
Nature Genetics|January 9, 2020
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Research in Nursing & Health|June 14, 2021
The generalizability of empirically derived syndromes of collateral-reported elder psychopathology across 11 societiesMasha Y Ivanova, Thomas M Achenbach, Leslie A Rescorla, et al.
Elife|December 4, 2018
Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesisStephin J Vervoort, Olivier G de Jong, M Guy Roukens, et al.
Cell Death and Differentiation|May 8, 2021
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatmentSafae Terrisse, Lisa Derosa, Valerio Iebba, et al.
Health Technology Assessment (Winchester, England)|September 4, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCTHelena Earl, Louise Hiller, Anne-Laure Vallier, et al.
Cancer Cell|September 25, 2020
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast CancerSusana Ros, Alan J Wright, Paula D'Santos, et al.
Nature Medicine|August 7, 2015
Toward understanding and exploiting tumor heterogeneityAsh A Alizadeh, Victoria Aranda, Alberto Bardelli, et al.
Cancer Research|November 8, 2024
Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast CancerAbigail Shea, Yaniv Eyal-Lubling, Daniel Guerrero-Romero, et al.
Pageof 43